E2 Erdman Antibiotic class review Flashcards
MOA for penicillins, cephalosporins, carbapenems, and monobactams (all the same)
inhibits cell wall synthesis
by binding to and inhibiting
PBPs
MOA for fluoroquinolones
Inhibit dna synthesis by inhibiting bacterial topoisomerases
MOA for macrolides
inhibits protein synthesis by binding to 50S ribosomal subunits
MOA for aminoglycosides
inhibits protein synthesis by irreversibly binding to 30S ribosomal subunits
MOA for vancomycin and dalbavancin
inhibits 2nd stage of cell wall synthesis by binding to D-Ala-D-Ala cell wall precursors
MOA for quinupristin and dalfopristin
inhibits protein synthesis by binding to 50S ribosomal subunits
MOA for linezolid and tedizolid
Inhibits protein synthesis by binding to 50S ribosomal subunits
MOA for daptomycin
causes membrane depolarization by inserting lipophilic tail in cell wall
MOA for telavancin and oritavancin
Inhibits cell wall synthesis by binding to D-Ala-D-Ala cell wall precursors AND causes membrane depolarization by inserting lipophilic tail in cell wall
MOA for tetracyclines and tetracycline analogs
inhibits protein synthesis by binding to 30S ribosomal subunit
MOA for trimethoprim-sulfamethoxazole
sequential inhibition of microbial folic acid synthesis pathway by inhibiting bacterial dihydropteroate synthetase and dihydrofolate reductase
MOA for polymyxins
binds to phospholipids in cell membrane causing displacement of Ca and Mg which leads to changes in cell wall permeability and leakage of cellular contents
MOA of clindamycin
inhibits protein synthesis by binding to 50S ribosomal subunits
MOA of metronidazole
prodrug activated by ferredoxins whose activated metabolites damage bacterial DNA
3 mechs of resistance for penicillins, cephalosporins, carbapenems, and monobactams (all the same) (one different thing with mono tho)
- b lactamases
- altered PBPs
- decreased pen through outer cell membrane (GNO)
- MONO ONLY: lacks altered PBPs
3 mechs of resistance for fluoroquinolones
- mutation in genes that code for DNA gyrase or topo IV (change in binding sites)
- efflux pumps
- dec pen through outer cell membrane (GNO)
2 resistance mechs for macrolides
- efflux (med)
- change in ribosomal binding site (erm)
3 resistance mechs for aminoglycosides
- altered uptake
- synthesis of aminoglycoside-modifying enzymes
- alteration in ribosomal binding sites (strepto)
1 resistance mech for vancomycin/dalbavancin
modification of the D-Ala-D-Ala binding site
1 resistance mech for quinupristin/dalfopristin
alteration in ribosomal binding site
1 resistance mech for linezolid/tedizolid
alteration in ribosomal binding site (rare)
1 resistance mech for daptomycin
altered cell membrane binding through loss of membrane protein
1 resistance mech for telavancin/oritavancin
modification of D-Ala-D-Ala vanco binding site
3 resistance mechs for tetracyclines
- tetracycline-specific efflux pumps
- ribosomal protection proteins
- enzymatic inactivation
1 resistance mech for tetracycline analogs
multidrug efflux pump
1 resistance mech for trimethoprim-sulfamethoxazole
mutation in dihydrofolate reductase or dihydropteroate synthase
1 resistance mech for polymyxins
alteration in outer cell membrane (dec in Ca or Mg content, dec in lipopolysaccharide content, dec in outer membrane proteins)
1 resistance mech for clindaymycin
alteration in ribosomal binding site
2 resistance mechs for metronidazole
- altered growth requirements
- reduced transcription of ferredoxin gene
any beta-lactam class
A. Bactericidal
B. Bacteriostatic
A
fluoroquinolones
A. Bactericidal
B. Bacteriostatic
A
macrolides
A. Bactericidal
B. Bacteriostatic
B
aminoglycosides
A. Bactericidal
B. Bacteriostatic
A
vancomycin/dalbavancin
A. Bactericidal
B. Bacteriostatic
A
quinupristin/dalfopristin
A. Bactericidal
B. Bacteriostatic
B
Linezolid/Tedizolid
A. Bactericidal
B. Bacteriostatic
B
daptomycin
A. Bactericidal
B. Bacteriostatic
A
telavancin/oritavancin
A. Bactericidal
B. Bacteriostatic
A
tetracyclines
A. Bactericidal
B. Bacteriostatic
B
tetracyclines analogs
A. Bactericidal
B. Bacteriostatic
B
trimethoprim/sulfamethoxazole
A. Bactericidal
B. Bacteriostatic
A
polymyxins
A. Bactericidal
B. Bacteriostatic
A
Clindamycin
A. Bactericidal
B. Bacteriostatic
B
Metronidazole
A. Bactericidal
B. Bacteriostatic
A
all beta-lactams
A. Time dependent
B. Conc dependent
A
fluoroquinolones
A. Time dependent
B. Conc dependent
B
macrolides
A. Time dependent
B. Conc dependent
A (azithromycin may be conc vs some organisms)
aminoglycosides
A. Time dependent
B. Conc dependent
B
vancomycin/dalbavancin
A. Time dependent
B. Conc dependent
A
Quinupristin/Dalfopristin
A. Time dependent
B. Conc dependent
A
Linezolid/Tedizolid
A. Time dependent
B. Conc dependent
TRICK, L=time, T=conc
daptomycin
A. Time dependent
B. Conc dependent
B
telavancin/oritavancin
A. Time dependent
B. Conc dependent
B
tetracyclines
A. Time dependent
B. Conc dependent
A
tetracycline analogs
A. Time dependent
B. Conc dependent
A
trimethoprim-sulfamethoxazole
A. Time dependent
B. Conc dependent
A
polymyxins
A. Time dependent
B. Conc dependent
B
clindamycin
A. Time dependent
B. Conc dependent
A
metronidazole
A. Time dependent
B. Conc dependent
B